First published · Last updated
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians
A journal article published 2026-08-19 reports a modified double-blind Delphi panel of US physicians examining optimization of bridging therapy prior to CAR-T therapy for multiple myeloma. The supplied excerpt included only the publisher and content type and provided no further study details.
Categories: public-health, science-and-space
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 5/10
- Geographic reach
- 5/10
- Global importance
- 3/10
- Impact magnitude
- 3/10
- Positivity
- 7/10
- Urgency
- 2/10
Why it matters
The study addresses optimization of bridging therapy before CAR-T treatment in multiple myeloma.

